Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141875 |
| CAS No | NA |
| Mol.F. | C34H43N5O4 |
| Mol.Wt. | 585.7 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141876 |
| CAS No | NA |
| Mol.F. | C30H35N5O3 |
| Mol.Wt. | 513.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141877 |
| CAS No | NA |
| Mol.F. | C30H35N5O3 |
| Mol.Wt. | 513.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141878 |
| CAS No | NA |
| Mol.F. | C30H36N6O4 |
| Mol.Wt. | 544.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141879 |
| CAS No | NA |
| Mol.F. | C21H16IN3O2 |
| Mol.Wt. | 469.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141880 |
| CAS No | NA |
| Mol.F. | C12H13N5O2 |
| Mol.Wt. | 259.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141881 |
| CAS No | NA |
| Mol.F. | C24H28N4O3 |
| Mol.Wt. | 420.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141882 |
| CAS No | NA |
| Mol.F. | C12H23N3O4 |
| Mol.Wt. | 273.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141883 |
| CAS No | NA |
| Mol.F. | C11H21N3O4 |
| Mol.Wt. | 259.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141884 |
| CAS No | NA |
| Mol.F. | C5H3N5O2 |
| Mol.Wt. | 165.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141885 |
| CAS No | NA |
| Mol.F. | C13H18N2O2 |
| Mol.Wt. | 234.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141886 |
| CAS No | NA |
| Mol.F. | C22H18N4O3 |
| Mol.Wt. | 386.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141887 |
| CAS No | NA |
| Mol.F. | C22H16N4O5 |
| Mol.Wt. | 416.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141888 |
| CAS No | NA |
| Mol.F. | C23H20N4O3 |
| Mol.Wt. | 400.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141889 |
| CAS No | NA |
| Mol.F. | C27H23N5O6 |
| Mol.Wt. | 513.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141890 |
| CAS No | NA |
| Mol.F. | C21H16N4O3 |
| Mol.Wt. | 372.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |